PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

Ontario is proposing to further expand pharmacists' scope of practice by adding to the list of minor ailments they can assess ...

Those treatments are readily available over the ... get a shingles vaccine to prevent shingles from affecting the eye. Shingles can cause pink eye and, in rare cases, damage to the cornea that ...

EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

Home treatments for shingles include calamine lotion ... it's also important to see a healthcare provider if the rash gets close to your eye. Shingles is an infection in which the herpes zoster virus ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

NanoViricides has signed a broad Memorandum of Understanding Agreement (MoU) with TheraCour encompassing all antiviral drugs developments on September 23, 2024, an important step that provides the ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

My hands shook as I texted my husband. I felt unmoored in my body, as if I’d awoken in a different house than the one where I ...

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...